Thyroid Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Thyroid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 236 trials

Recruiting
Phase 2

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Metastic Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)54 enrolled1 locationNCT04927416
Recruiting
Not Applicable

The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

Thyroid Nodules
Chinese PLA General Hospital1,500 enrolled1 locationNCT06340945
Recruiting
Phase 2

Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)

Thyroid CancerCancer of the Thyroid
Washington University School of Medicine34 enrolled1 locationNCT07092514
Recruiting
Phase 1

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Breast CancerHead and Neck Squamous Cell CarcinomaMetastatic Malignant Solid Neoplasm+14 more
Anusha Kalbasi18 enrolled3 locationsNCT04119024
Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Endocrine TumorsNeuroblastomaThyroid Neoplasms+2 more
National Cancer Institute (NCI)2,415 enrolled1 locationNCT01005654
Recruiting

Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy

Thyroid CarcinomaPediatric Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna2,550 enrolled2 locationsNCT07473518
Recruiting

Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.

Thyroid Cancer
M.D. Anderson Cancer Center459 enrolled1 locationNCT06507878
Recruiting

Studies on Tumors of the Thyroid

Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2,500 enrolled1 locationNCT00001160
Recruiting

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Radiofrequency AblationPapillary Thyroid CancerLow Risk
M.D. Anderson Cancer Center50 enrolled1 locationNCT07140757
Recruiting

Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer

Thyroid Gland CarcinomaThyroid Gland Nodule
Jonsson Comprehensive Cancer Center250 enrolled1 locationNCT04742608
Recruiting

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

Non-Medullary Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)500 enrolled1 locationNCT01109420
Recruiting

Postoperative Hypocalcemia After Thyroidectomy

Thyroid CancerPostoperative ComplicationsThyroid Nodule+2 more
Minia University600 enrolled1 locationNCT07428057
Recruiting
Phase 1

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

MelanomaNon-small Cell Lung CancerThyroid Cancer+10 more
Pfizer124 enrolled79 locationsNCT05538130
Recruiting

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

Stage III Thyroid Gland Medullary Carcinoma AJCC v8Advanced Thyroid Gland Medullary CarcinomaStage IV Thyroid Gland Medullary Carcinoma AJCC v8+3 more
M.D. Anderson Cancer Center2,030 enrolled2 locationsNCT04216732
Recruiting
Not Applicable

Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers

Differentiated Thyroid Cancer
University College, London456 enrolled33 locationsNCT05604963
Recruiting
Not Applicable

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

NeoplasmPsychological DistressPost Traumatic Stress Disorder (PTSD)+1 more
Università Cattolica di Milano25 enrolled1 locationNCT07447089
Recruiting
Phase 3

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Refractory Differentiated Thyroid Gland Carcinoma
ECOG-ACRIN Cancer Research Group264 enrolled112 locationsNCT06475989
Recruiting
Not Applicable

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

MelanomaBreast Cancer, NOSCNS Primary Tumor, NOS+9 more
Eastern Cooperative Oncology Group400 enrolled347 locationsNCT05108298
Recruiting
Phase 3

Selective Neck Dissection Versus Modified Neck Dissection in PTC

Thyroid Cancer
Fudan University250 enrolled1 locationNCT06554652
Recruiting
Phase 3

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Thyroid Cancer
Fudan University124 enrolled1 locationNCT06558981